Most Read Articles
12 Jun 2020
At a scientific symposium co-organized by the Hong Kong Medical Association and the Hong Kong Paediatric Nurses Association held on 17 October 2019 in Hong Kong, local and overseas experts in paediatric infectious diseases discussed prevention strategies for invasive meningococcal disease (IMD), with a special focus on serogroup B disease: the most common cause of IMD in all age groups.

Meningitis B vaccine: A solution for preventing invasive meningococcal disease

12 Jun 2020
At a scientific symposium co-organized by the Hong Kong Medical Association and the Hong Kong Paediatric Nurses Association held on 17 October 2019 in Hong Kong, local and overseas experts in paediatric infectious diseases discussed prevention strategies for invasive meningococcal disease (IMD), with a special focus on serogroup B disease: the most common cause of IMD in all age groups.

For adverse event reporting, please call GlaxoSmithKline Limited at (852) 3189 8989 (Hong Kong).
Full Prescribing Information is available upon request. Please read the full prescribing information prior to administration, available from GlaxoSmithKline Limited.
Trade marks are owned by or licensed to the GSK group of companies.
©2020 GSK group of companies or its licensor.

Related MIMS Drugs

Editor's Recommendations
Most Read Articles
12 Jun 2020
At a scientific symposium co-organized by the Hong Kong Medical Association and the Hong Kong Paediatric Nurses Association held on 17 October 2019 in Hong Kong, local and overseas experts in paediatric infectious diseases discussed prevention strategies for invasive meningococcal disease (IMD), with a special focus on serogroup B disease: the most common cause of IMD in all age groups.